Illustration of semaglutide (red) activating a key receptor called GLP-1 (blue)
Juan Gaertner/Scientific Image Library/Alamy
An animal study showed that the active ingredient in Ozempic and Wegovy, a drug called semaglutide, can have direct beneficial effects on the heart within weeks, in addition to long-term weight loss benefits.
The results suggest that people with heart disease who do not have type 2 diabetes or obesity, which semaglutide is primarily used to treat, may also benefit from taking this type of medication. “It may be that we are missing out…